Howard Marks's CORZ Position Overview
Howard Marks (via Oaktree Capital Management Lp) currently holds 9.4 M shares of Core Scientific, Inc. (CORZ) worth $139.9 M, representing 2.23% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Howard Marks has maintained this position in CORZ for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 1.95 M shares.
Analysis based on 13F filings available since 2013 Q2
Howard Marks's Core Scientific (CORZ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Core Scientific (CORZ) Trades by Howard Marks
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.05 M | Add 12.57% | 9.4 M | $14.88 |
| Q4 2025 | +1.95 M | Add 30.47% | 8.35 M | $14.56 |
| Q3 2025 | +6.4 M | New Buy | 6.4 M | $17.94 |
Howard Marks's Core Scientific Investment FAQs
Howard Marks first purchased Core Scientific, Inc. (CORZ) in Q3 2025, acquiring 6,400,708 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Howard Marks has held Core Scientific, Inc. (CORZ) for 3 quarters since Q3 2025.
Howard Marks's largest addition to Core Scientific, Inc. (CORZ) was in Q3 2025, adding 6,400,708 shares worth $114.83 M.
According to the latest 13F filing for Q1 2026, Howard Marks's firm, Oaktree Capital Management Lp, owns 9,400,708 shares of Core Scientific, Inc. (CORZ), valued at approximately $139.9 M.
As of the Q1 2026 filing, Core Scientific, Inc. (CORZ) represents approximately 2.23% of Howard Marks's publicly disclosed stock portfolio, making it one of their key holdings.
Howard Marks's peak holding in Core Scientific, Inc. (CORZ) was 9,400,708 shares, as reported at the end of Q1 2026.